Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32005 total
Red Rock Resorts enters September with a familiar tension: the Street is broadly bullish, targets sit well above the current price, yet the stock has shed 13% in a month and short sellers are quietly adding to…
SPCX enters September with the short-versus-analyst divergence that defined August now resolving in the bulls' favour — shorts are quietly covering, borrow is loose, and Oppenheimer just raised its target to $280. The…
Hubbell Incorporated has dropped 4.5% in the past week and 6.2% over the past month, closing at $443.31 — but what separates this week's setup from a routine industrial selloff is how dramatically options positioning…
NANR, State Street's S&P North American Natural Resources ETF, heads into September with its lending market meaningfully looser than at any point in the past six weeks — a sharp reversal from the squeeze conditions…
LivaNova heads into the final stretch of summer with an unusual split: short interest climbing at its fastest pace in months, while options traders have swung to their most bullish posture in over a year. The short…
SPMO, the Invesco S&P 500 Momentum ETF, pulls into September with an interesting internal contradiction: short interest has jumped sharply over the past month yet the options market has shifted notably more bullish…
HPE reports its Q3 results today against a backdrop that has shifted meaningfully since the last two preview notes: short sellers have covered aggressively, analyst conviction has hardened, and the stock has pulled…
XLRE enters September with a quiet but persistent shift in tone — options traders have grown more defensive even as short sellers retreat, creating a small but notable divergence in how the market is leaning on the…
CIBR, the First Trust NASDAQ Cybersecurity ETF, enters September with the most notable short-side activity it has seen all year — yet the borrow market tells a more nuanced story than the headline numbers suggest. The…
OLLI reported earnings on September 2 and the market's verdict was swift: shares fell 4.1% on the day to $72.34, extending a week-long decline of 3% and leaving the stock down roughly 34% year-to-date. The week's most…
WING enters September with a stock down 15% over the past month, a bear case that's getting harder to dismiss, and a Street that slashed targets after Q2 but largely stayed in the bull camp — a split that defines the…
JETS has spent the past month becoming one of the most-shorted ETFs in the market, and that pressure intensified again this week even as the fund fell sharply. Short interest has nearly doubled since late July. It…
Zevra Therapeutics heads into September with a striking divergence: short sellers have spent a month covering positions aggressively, while institutional investors are quietly building some of the largest stakes the…
Equinix enters September with an odd split personality: the stock is down 4.3% on the week to $1,027.59, yet nearly every positioning metric is moving in the bulls' favour. The short side has continued to deflate since…
Medtronic delivered its September 1 earnings and the analyst community has responded with a near-uniform wave of target increases — a post-print reaction that shifts the story from pre-earnings anticipation to whether…
OKTA surged 32% on its August 26 earnings print, hit $172 in the days that followed, and has since given back ground — the question now is whether the pullback is digestion or disappointment. The post-earnings…
Viking Therapeutics enters September with nearly 20% of its free float sold short and options traders leaning more bullish than they have been in months — a split that makes the stock's positioning more nuanced than…
SSMR enters September with an unusual split: a freshly covered stock with unanimous bullish analyst backing, yet one that has just surrendered nearly 10% in a single week after a standout August. The Street's…
Limbach Holdings gained 8.7% on Tuesday and finished the week up 6.9% to $44.79 — a sharp rebound, but one that lands against a brutal backdrop: the stock is still down 38% over the past month, following an…
RARE enters September with an unusual split: the Street just raised targets from every direction, yet short sellers have quietly rebuilt their positions to a 30-day high. The short interest story is the week's central…
